当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析

科前生物

(688526)

  

流通市值:67.59亿  总市值:67.59亿
流通股本:4.66亿   总股本:4.66亿

科前生物(688526)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.60亿元,每股收益0.56元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益385867.19万元,未分配利润199549.49万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产443196.49万元,负债57329.30万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入665,506,663.22400,510,475.63204,929,240.41,064,074,588.89
营业总成本393,227,605.15241,479,146.09117,548,562.59547,826,665.17
营业利润297,508,255.32173,596,349.33100,624,673.5459,131,690.91
利润总额296,811,632.39172,929,832.1100,009,570.54457,580,664.5
净利润260,007,447.22152,236,148.187,075,680.66395,580,552.7
其他综合收益-7,555,091.94,375,869.323,322,297.4725,333,622.92
综合收益总额252,452,355.32156,612,017.4290,397,978.13420,914,175.62
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,396,570,097.092,571,347,456.932,472,776,254.392,566,086,573.76
非流动资产合计2,035,394,753.661,899,508,520.642,145,607,824.282,105,162,897.25
资产总计4,431,964,850.754,470,855,977.574,618,384,078.674,671,249,471.01
流动负债合计485,279,988.47620,430,404.21637,309,672.55758,252,066.9
非流动负债合计88,012,962.2785,979,198.7977,395,391.8375,340,080.38
负债合计573,292,950.74706,409,603714,705,064.38833,592,147.28
归属于母公司股东权益合计3,857,235,244.363,762,788,667.173,901,801,603.233,835,627,197.55
股东权益合计3,858,671,900.013,764,446,374.573,903,679,014.293,837,657,323.73
负债和股东权益合计4,431,964,850.754,470,855,977.574,618,384,078.674,671,249,471.01
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计684,071,524.53461,874,127.61276,340,855.261,131,870,298.28
经营活动现金流出小计410,980,647.73300,307,659.2143,254,275.52593,836,368.39
经营活动产生的现金流量净额273,090,876.8161,566,468.41133,086,579.74538,033,929.89
投资活动现金流入小计939,841,847.1720,914,865.68446,189,764.612,043,866,185.89
投资活动现金流出小计911,560,328.8468,323,370.46220,764,662.942,372,862,356.98
投资活动产生的现金流量净额28,281,518.3252,591,495.22225,425,101.67-328,996,171.09
筹资活动现金流入小计97,000,00097,000,00050,059,095.89344,118,858.75
筹资活动现金流出小计562,226,184.63379,833,467.77177,480,673.8446,544,220.24
筹资活动产生的现金流量净额-465,226,184.63-282,833,467.77-127,421,577.91-102,425,361.49
汇率变动对现金及现金等价物的影响-11,538.76-1,830.060.0654,930.5
现金及现金等价物净增加额-163,865,328.29131,322,665.8231,090,103.56106,667,327.81
期末现金及现金等价物余额393,503,454.65688,691,448.74788,458,886.5557,368,782.94
最新报告期:2024-11-04
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华安证券王莺,万定宇0.770.981.172024-11-04
开源证券陈雪丽0.791.001.162024-11-03
国海证券熊子兴,程一胜0.800.941.112024-11-03
华泰证券熊承慧0.750.931.062024-10-30
国信证券李瑞楠,鲁家瑞0.901.051.082024-09-06
TOP↑